Brown University recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
121 SOUTH MAIN STREET 9TH FLOOR PROVIDENCE, RI 02903
As of the latest 13F report, the guru’s equity portfolio contained 5 stocks valued at a total of $239.00Mil. The top holdings were OWL(65.51%), ORCC(30.59%), and PROK(2.87%).
According to GuruFocus data, these were Brown University’s top five trades of the quarter.
Amazon.com Inc
The guru sold out of their 165,800-share investment in NAS:AMZN. Previously, the stock had a 7.6% weight in the equity portfolio. Shares traded for an average price of $98.78 during the quarter.
On 01/24/2023, Amazon.com Inc traded for a price of $96.31999999999999 per share and a market cap of $982.62Bil. The stock has returned -33.36% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Amazon.com Inc has a price-earnings ratio of 88.37, a price-book ratio of 7.15, a price-earnings-to-growth (PEG) ratio of 2.11, a EV-to-Ebitda ratio of 21.00 and a price-sales ratio of 1.98.
The price-to-GF Value ratio is 0.50, earning the stock a GF Value rank of 4.
Royalty Pharma PLC
The guru sold out of their 331,759-share investment in NAS:RPRX. Previously, the stock had a 5.41% weight in the equity portfolio. Shares traded for an average price of $41.74 during the quarter.
On 01/24/2023, Royalty Pharma PLC traded for a price of $38.26 per share and a market cap of $16.88Bil. The stock has returned -1.27% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Royalty Pharma PLC has a price-earnings ratio of 79.87, a price-book ratio of 2.74, a EV-to-Ebitda ratio of 19.95 and a price-sales ratio of 9.39.
Blue Owl Capital Inc
Brown University reduced their investment in NYSE:OWL by 989,097 shares. The trade had a 3.7% impact on the equity portfolio. During the quarter, the stock traded for an average price of $10.56.
On 01/24/2023, Blue Owl Capital Inc traded for a price of $12.51 per share and a market cap of $5.57Bil. The stock has returned 5.37% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Blue Owl Capital Inc has a price-book ratio of 3.34, a EV-to-Ebitda ratio of 34.55 and a price-sales ratio of 9.27.
ProKidney Corp
The guru established a new position worth 1,000,000 shares in NAS:PROK, giving the stock a 2.87% weight in the equity portfolio. Shares traded for an average price of $9.550000000000001 during the quarter.
On 01/24/2023, ProKidney Corp traded for a price of $9.76 per share and a market cap of $600.63Mil. The stock has returned 0.00% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, ProKidney Corp has a EV-to-Ebitda ratio of -1.03.
VanEck Gold Miners ETF
The guru sold out of their 541,096-share investment in ARCA:GDX. Previously, the stock had a 4.4% weight in the equity portfolio. Shares traded for an average price of $25.28 during the quarter.
On 01/24/2023, VanEck Gold Miners ETF traded for a price of $32.73 per share and a market cap of $13.78Bil. The stock has returned 5.82% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, VanEck Gold Miners ETF has a price-earnings ratio of 18.94 and a price-book ratio of 1.53.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
